Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ADOC
Edoc Acquisition Corp. Class A
stock NASDAQ

Inactive
Mar 21, 2024
2.85USD-64.464%(-5.17)589,811
Pre-market
0.00USD-100.000%(-8.02)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 6, 2022
12:00PM EST  ADOCIA SA, a French socit anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon, (Euronext Paris: FR0011184241 ADOC) a clinical stage biopharmaceutical company focused on diabetes treatments and other metabolic diseases with innovative formulations of peptides and proteins, announced today its financial calendar for 2022.   GlobeNewswire Inc
Oct 14, 2021
01:30AM EDT  -- This Phase 3 clinical program will enroll over 1,300 people with diabetes and is expected to be pivotal for product registration in China -- First patient in the study will trigger a milestone payment to Adocia -- BC Lispro addresses the Chinese prandial insulin market which is approx. $1.4bn today with double-digit growth   GlobeNewswire Inc
Sep 10, 2021
01:30AM EDT  Adocia to Participate in the H.C. Wainwright 23rd Annual Global   GlobeNewswire Inc
Jun 29, 2021
12:03PM EDT  -- For the first time, a unique combination of two key hormones involved in glycemic control, a rapid acting insulin analog and an amylin analog, is tested in a single pump -- BioChaperone Lispro and Pramlintide coformulations safety, pharmacokinetic and glycemic control will be evaluated compared to insulin lispro   GlobeNewswire Inc
Jun 15, 2021
01:30AM EDT  ADOCIA Announces M1Pram Clinical Data Presentation at the American   GlobeNewswire Inc
May 28, 2021
05:01PM EDT  EDOC Acquisition Corp. Reports Regained Nasdaq Compliance Related To Delayed Annual Report   Benzinga
May 26, 2021
01:30AM EDT  Adocia Expands Clinical Development to Obesity with Patent   GlobeNewswire Inc
Apr 22, 2021
05:28PM EDT  Edoc Acquisition Reports Received Notice From Nasdaq Listing Department Related To Failure To File 10-K In Timely Fashion   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC